7725.TWO LabTurbo Biotech Corporation
- Market cap
- TWD 997M
- P/E
- -
- P/B
- 0.95x
- ROE
- -29.5%
- Dividend yield
- 2.42%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2025.
Is 7725.TWO undervalued?
Graham numberThe Graham number of LabTurbo Biotech Corporation cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
LabTurbo Biotech Corporation fundamental analysis
No fundamental analysis for LabTurbo Biotech Corporation yet.
LabTurbo Biotech Corporation stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About LabTurbo Biotech Corporation
LabTurbo Biotech Corporation engages in the research, manufacture, and sale of gene detection systems and kits in Taiwan, the United States, the Czech Republic, Spain, France, Israel, Singapore, the Philippines, and Malaysia. It serves hospitals. The company was founded in 2000 and is based in Taipei, Taiwan.
Full company profileLabTurbo Biotech Corporation financial statements
2025 annualized: Fiscal year 2025 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2025, the balance sheet is the latest quarter. Figures change when the annual report is published.
LabTurbo Biotech Corporation annual financial statements
| Item | 2021 | 2022 | 2023 | 2024 | 2025 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 979M | 1.34B | 188M | 73.0M | 147M |
| Gross Profit | 684M | 995M | 31.1M | 17.0M | -88.5M |
| Operating Income | 584M | 798M | -179M | -183M | -374M |
| EBITDA | 600M | 865M | -8.87M | 53.5M | -274M |
| Net Income | 459M | 643M | -64.3M | 13.0M | -344M |
| EPS | 10 | 13 | -1.33 | 0.27 | -7.17 |
| Balance Sheet | |||||
| Total Assets | 1.36B | 1.78B | 1.40B | 1.39B | 1.22B |
| Total Liabilities | 304M | 240M | 66.0M | 76.1M | 61.3M |
| Shareholders' Equity | 1.06B | 1.54B | 1.34B | 1.31B | 1.16B |
| Cash & Short-term Investments | 605M | 1.11B | 853M | 886M | 173M |
| Total Debt | 52.7M | 42.5M | 10.9M | 28.2M | - |
| Cash Flow | |||||
| Operating Cash Flow | 256M | 861M | -150M | -121M | -309M |
| Capital Expenditure | 124M | 60.0M | 26.7M | 19.9M | 3.63M |
| Free Cash Flow | 131M | 801M | -176M | -140M | -312M |
| Ratios | |||||
| ROE | 43.2% | 41.8% | -4.8% | 1.0% | -29.5% |
| ROA | 33.6% | 36.2% | -4.6% | 0.9% | -28.1% |
| Net Profit Margin | 46.8% | 47.9% | -34.2% | 17.8% | -233.0% |
| Debt to Equity | 0.05x | 0.03x | 0.01x | 0.02x | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
LabTurbo Biotech Corporation dividends
- Dividend yield
- 2.42%
- Forward dividend
- 0.20 TWD
- Payout ratio
- 186.4%
- Ex-dividend date
- Jul 8, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2024 | TWD 24.2M | 0.50 | 186.4% |
| 2023 | TWD 145M | 3.00 | - |
| 2022 | TWD 145M | 2.96 | 22.6% |
| 2021 | TWD 18.9M | 0.42 | 4.1% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns LabTurbo Biotech Corporation
Ownership data of LabTurbo Biotech Corporation is not available yet.
LabTurbo Biotech Corporation company profile
- Company name
- LabTurbo Biotech Corporation
- Ticker
- 7725.TWO
- ISIN
- TW0007725004
- Exchange
- Taiwan OTC Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- Fiscal year end
- December
- Address
- No. 150, Chengde Rd., Taipei, Taiwan, 111
- Phone
- 886 2 2889 1136
- Website
- labturbo.com
About LabTurbo Biotech Corporation
LabTurbo Biotech Corporation engages in the research, manufacture, and sale of gene detection systems and kits in Taiwan, the United States, the Czech Republic, Spain, France, Israel, Singapore, the Philippines, and Malaysia. It serves hospitals. The company was founded in 2000 and is based in Taipei, Taiwan.